Stocks · Health care · Pharmaceutical Preparations

GENELUX Corp

GNLX Clue Score27

United States Fiscal year ends December CIK 0001231457 Results filed 25 Mar 2025

Add to watchlist

What the insiders did Net selling

By person

17 insiders · 152 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Aladar Szalay

10% owner

—

$11.81M (59)

−$11.81M

599,821

1.33%

$1.21M

−23.7%

Yong Yu

Chief Scientific Officer

— (1)

$3.28M (27)

−$3.28M

258,020

0.5703%

$518.96K

+65.1%

John Thomas

Director

— (1)

$454.50K (10)

−$454.50K

501,193

1.11%

$1.01M

—

Thomas Zindrick

President and CEO

— (1)

$453.44K (10)

−$453.44K

1,623,338

3.59%

$3.27M

+685.4%

Sean Ryder

General Counsel

— (1)

$332.50K (4) scheduled

−$332.50K

47,621

0.1053%

$95.78K

+2,161%

Joseph Cappello

Chief Technical Officer

—

$155.81K (11)

−$155.81K

317,812

0.7024%

$639.22K

—

James L Tyree

Director

— (1)

$131.98K (4)

−$131.98K

96,483

0.2132%

$194.06K

+5,477%

John W Smither

Director

— (1)

$53.60K (2)

−$53.60K

91,403

0.2020%

$183.84K

+10,056%

Ralph Smalling

Head of Regulatory

— (1)

$43.28K (11)

−$43.28K

67,611

0.1494%

$135.99K

+1,067%

Doug Samuelson

Vice President, Finance

—

$30.78K (1)

−$30.78K

2,303

0.0051%

$4.63K

—

Caroline Jewett

Head of Quality

—

$22.74K (2)

−$22.74K

16,174

0.0357%

$32.53K

—

Lourie S. Zak

Chief Financial Officer

— (1)

$4.92K (1)

−$4.92K

82,452

0.1822%

$165.84K

+1,152%

Qian Zhang

Associate VP, Research

$1.25K (1)

—

+$1.25K

139,533

0.3084%

$280.64K

+4.7%

Mary Mirabelli

Director

— (1)

—

$0.00

102,693

0.2270%

$206.55K

—

Matthew Pulisic

Chief Financial Officer

—

—

—

278,906

0.6164%

$560.96K

—

Eric Groen

General Counsel

—

—

—

233,957

0.5171%

$470.56K

—

Gabe Woodward

Director

—

—

—

6,984

0.0154%

$14.05K

—